Candesartan Cilexetil and Hydrochlorthiazide Tablets 16mg/12.5mg, 32mg/12.5mg-SmPC

Page 1

Cande sartan Hydrochlori de 16 mg/12. 5mg, 3 2mg/ 12.5 mg Tablets TajP harma : Uses, Side Effects, I nteractions, Pi ctures, War nings, Candesartan Hydr ochl orideD osage & Rx I nfo |Candesartan Hydr ochloride Uses, Side E ffects - Antihyperten sive, Candesartan Hydr ochloride: I ndi cations, Side Effects, Warning s,Candesartan Hydr ochl oride - Drug Infor mation - TajPhar ma,Ca ndesarta n Hydrochloridedose Taj phar maceuticals Candesartan Hydrochl orideintera ctions, Taj Pharma ce utical Candesartan Hydr ochloride contraindica tions, Cande sartan Hydrochlori de price, Candesartan Hydr ochloride Taj P harma Antiang inal Cande sartan Hydrochlori de Tablets SMP C- Taj Pharma Stay conne cted to all updated on Ca ndesarta n Hydrochloride Taj Phar mace uticals Taj pharma ceutical s Mumbai. Patient I nfor mation Lea flets, SMPC.

Candesartan and Hydrochlorothiazide Tablets 16mg/12.5mg, 32mg/12.5mg 1. Name of the medicinal product Candesartan and Hydrochlorothiazide Tablets 16mg/12.5mg Taj Pharma Candesartan and Hydrochlorothiazide Tablets 32mg/12.5mg Taj Pharma

2. Qualitative and quantitative composition a) Each film coated tablet contains: Candesartan Cilexetil USP 16mg Hydrochlorothiazide USP 12.5mg Excipients q.s. Colour: Lake Ponceau 4R & Titanium Dioxide USP. b) Each film coated tablet contains: Candesartan Cilexetil USP 32mg Hydrochlorothiazide USP 12.5mg Excipients q.s. Colour: Lake Ponceau 4R & Titanium Dioxide USP. For the full list of excipients, see section 6.1

3. Pharmaceutical form Film coated tablet.

4. Clinical particulars 4.1 Therapeutic indications Candesartan Hydrochlorothiazide is indicated for the:

-

Treatment of essential hypertension in adult patients whose blood pressure is not optimally controlled with candesartan cilexetil or hydrochlorothiazide monotherapy. 4.2 Posology and method of administration Posology The recommended dose of Candesartan Hydrochlorothiazide is one tablet once daily. Dose titration with the individual components (candesartan cilexetil and hydrochlorothiazide) is recommended. When clinically appropriate a direct change from monotherapy to Candesartan Hydrochlorothiazide may be considered. Dose titration of candesartan cilexetil is recommended when switching from hydrochlorothiazide monotherapy. Candesartan Hydrochlorothiazide may be administered in patients whose blood pressure is not optimally controlled with candesartan cilexetil or hydrochlorothiazide monotherapy or Candesartan Hydrochlorothiazide at lower doses (see sections 4.3, 4.4, 4.5 and 5.1). Most of the antihypertensive effect is usually attained within 4 weeks of initiation of treatment. Special populations Elderly population No dose adjustment is necessary in elderly patients. Patients with intravascular volume depletion Dose titration of candesartan cilexetil is recommended in patients at risk for hypotension, such as patients with possible volume depletion (an initial dose of candesartan cilexetil of 4 mg may be considered in these patients). Patients with renal impairment


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.